サマリー

急性虚血性脳卒中治療薬の世界市場2023-2027年
Technavioは急性虚血性脳卒中治療薬市場を監視しており、2023年から2027年の間に1524.49万ドル、予測期間中にCAGR5.72%で加速して成長すると予測しています。当レポートでは、急性虚血性脳卒中治療薬市場について、全体的な分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、疾患の有病率の上昇、NOACsの採用の増加、座りがちなライフスタイルの有病率の上昇によって牽引されています。
Technavioの急性虚血性脳卒中治療薬市場は、以下のように区分されています。
タイプ別
- 血栓溶解薬
- 抗凝固剤
- 抗血小板剤
- 抗高血圧薬
販売チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域（ROW）
本調査では、AIS研究における付加価値であるTBIが、今後数年間の急性虚血性脳卒中治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、ゲノム医療の出現と強力なパイプラインは、市場の相当な需要につながるでしょう。
Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。急性虚血性脳卒中治療薬市場に関する当レポートは、以下の分野を対象としています。
- 急性虚血性脳卒中治療薬市場のサイジング
- 急性虚血性脳卒中治療薬市場の予測
- 急性虚血性脳卒中治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Athersys Inc.、Bayer AG、Biogen Inc、Boehringer Ingelheim International GmbH、Medtronic Plc、NoNO Inc、SanBio Co Ltd、Stryker Corp、Amgen Inc、AstraZeneca Plc、Bristol Myers Squibb Co、第一三共Inc.含む複数の主要急性脳卒中治療剤市場ベンダーについての詳しい分析が掲載されています。(株)エフ・ホフマン・ラ・ロシュ、ジョンソン・エンド・ジョンソン、メルク・アンド・カンパニー、(株)エヌ・ティ・ティ・ドコモInc.、Pfizer Inc.、Sanofi SA、Teva Pharmaceutical Industries Ltd.の7社です。また、急性虚血性脳卒中治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/acute-ischemic-stroke-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
o 4.2 Bargaining power of buyers
o Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 4.3 Bargaining power of suppliers
o Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 4.4 Threat of new entrants
o Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027
o 4.5 Threat of substitutes
o Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027
o 4.6 Threat of rivalry
o Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027
o 4.7 Market condition
o Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 25: Chart on Type - Market share 2022-2027 (%)
o Exhibit 26: Data Table on Type - Market share 2022-2027 (%)
o 5.2 Comparison by Type
o Exhibit 27: Chart on Comparison by Type
o Exhibit 28: Data Table on Comparison by Type
o 5.3 Thrombolytics - Market size and forecast 2022-2027
o Exhibit 29: Chart on Thrombolytics - Market size and forecast 2022-2027 ($ million)
o Exhibit 30: Data Table on Thrombolytics - Market size and forecast 2022-2027 ($ million)
o Exhibit 31: Chart on Thrombolytics - Year-over-year growth 2022-2027 (%)
o Exhibit 32: Data Table on Thrombolytics - Year-over-year growth 2022-2027 (%)
o 5.4 Anticoagulants - Market size and forecast 2022-2027
o Exhibit 33: Chart on Anticoagulants - Market size and forecast 2022-2027 ($ million)
o Exhibit 34: Data Table on Anticoagulants - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Chart on Anticoagulants - Year-over-year growth 2022-2027 (%)
o Exhibit 36: Data Table on Anticoagulants - Year-over-year growth 2022-2027 (%)
o 5.5 Antiplatelets - Market size and forecast 2022-2027
o Exhibit 37: Chart on Antiplatelets - Market size and forecast 2022-2027 ($ million)
o Exhibit 38: Data Table on Antiplatelets - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Chart on Antiplatelets - Year-over-year growth 2022-2027 (%)
o Exhibit 40: Data Table on Antiplatelets - Year-over-year growth 2022-2027 (%)
o 5.6 Antihypertensives - Market size and forecast 2022-2027
o Exhibit 41: Chart on Antihypertensives - Market size and forecast 2022-2027 ($ million)
o Exhibit 42: Data Table on Antihypertensives - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Chart on Antihypertensives - Year-over-year growth 2022-2027 (%)
o Exhibit 44: Data Table on Antihypertensives - Year-over-year growth 2022-2027 (%)
o 5.7 Other therapeutics - Market size and forecast 2022-2027
o Exhibit 45: Chart on Other therapeutics - Market size and forecast 2022-2027 ($ million)
o Exhibit 46: Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
o Exhibit 48: Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
o 5.8 Market opportunity by Type
o Exhibit 49: Market opportunity by Type ($ million)
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 50: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 51: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 52: Chart on Comparison by Distribution Channel
o Exhibit 53: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacies - Market size and forecast 2022-2027
o Exhibit 54: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 55: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 57: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o 6.4 Retail pharmacies - Market size and forecast 2022-2027
o Exhibit 58: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 59: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 61: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o 6.5 Online pharmacies - Market size and forecast 2022-2027
o Exhibit 62: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 65: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 66: Market opportunity by Distribution Channel ($ million)
• 7 Customer Landscape
o 7.1 Customer landscape overview
o Exhibit 67: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 8 Geographic Landscape
o 8.1 Geographic segmentation
o Exhibit 68: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 69: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 8.2 Geographic comparison
o Exhibit 70: Chart on Geographic comparison
o Exhibit 71: Data Table on Geographic comparison
o 8.3 North America - Market size and forecast 2022-2027
o Exhibit 72: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 8.4 Europe - Market size and forecast 2022-2027
o Exhibit 76: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 79: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 8.5 Asia - Market size and forecast 2022-2027
o Exhibit 80: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 83: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 8.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 84: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 87: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 8.7 US - Market size and forecast 2022-2027
o Exhibit 88: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 91: Data Table on US - Year-over-year growth 2022-2027 (%)
o 8.8 UK - Market size and forecast 2022-2027
o Exhibit 92: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 95: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 8.9 Germany - Market size and forecast 2022-2027
o Exhibit 96: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 99: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 8.10 China - Market size and forecast 2022-2027
o Exhibit 100: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 103: Data Table on China - Year-over-year growth 2022-2027 (%)
o 8.11 Canada - Market size and forecast 2022-2027
o Exhibit 104: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 107: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 8.12 Market opportunity By Geographical Landscape
o Exhibit 108: Market opportunity By Geographical Landscape ($ million)
• 9 Drivers, Challenges, and Trends
o 9.1 Market drivers
o 9.2 Market challenges
o 9.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 9.4 Market trends
• 10 Vendor Landscape
o 10.1 Overview
o 10.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 10.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 10.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 11 Vendor Analysis
o 11.1 Vendors covered
o Exhibit 113: Vendors covered
o 11.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 11.3 Amgen Inc.
o Exhibit 115: Amgen Inc. - Overview
o Exhibit 116: Amgen Inc. - Product / Service
o Exhibit 117: Amgen Inc. - Key offerings
o 11.4 AstraZeneca Plc
o Exhibit 118: AstraZeneca Plc - Overview
o Exhibit 119: AstraZeneca Plc - Product / Service
o Exhibit 120: AstraZeneca Plc - Key news
o Exhibit 121: AstraZeneca Plc - Key offerings
o 11.5 Athersys Inc.
o Exhibit 122: Athersys Inc. - Overview
o Exhibit 123: Athersys Inc. - Product / Service
o Exhibit 124: Athersys Inc. - Key offerings
o 11.6 Bayer AG
o Exhibit 125: Bayer AG - Overview
o Exhibit 126: Bayer AG - Business segments
o Exhibit 127: Bayer AG - Key offerings
o Exhibit 128: Bayer AG - Segment focus
o 11.7 Biogen Inc.
o Exhibit 129: Biogen Inc. - Overview
o Exhibit 130: Biogen Inc. - Product / Service
o Exhibit 131: Biogen Inc. - Key offerings
o 11.8 Boehringer Ingelheim International GmbH
o Exhibit 132: Boehringer Ingelheim International GmbH - Overview
o Exhibit 133: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 134: Boehringer Ingelheim International GmbH - Key news
o Exhibit 135: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 136: Boehringer Ingelheim International GmbH - Segment focus
o 11.9 Bristol Myers Squibb Co.
o Exhibit 137: Bristol Myers Squibb Co. - Overview
o Exhibit 138: Bristol Myers Squibb Co. - Product / Service
o Exhibit 139: Bristol Myers Squibb Co. - Key offerings
o 11.10 Daiichi Sankyo Co. Ltd.
o Exhibit 140: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 141: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 142: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 143: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 144: Daiichi Sankyo Co. Ltd. - Segment focus
o 11.11 F. Hoffmann La Roche Ltd.
o Exhibit 145: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 146: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 147: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 148: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 149: F. Hoffmann La Roche Ltd. - Segment focus
o 11.12 Johnson and Johnson
o Exhibit 150: Johnson and Johnson - Overview
o Exhibit 151: Johnson and Johnson - Business segments
o Exhibit 152: Johnson and Johnson - Key news
o Exhibit 153: Johnson and Johnson - Key offerings
o Exhibit 154: Johnson and Johnson - Segment focus
o 11.13 Medtronic Plc
o Exhibit 155: Medtronic Plc - Overview
o Exhibit 156: Medtronic Plc - Business segments
o Exhibit 157: Medtronic Plc - Key news
o Exhibit 158: Medtronic Plc - Key offerings
o Exhibit 159: Medtronic Plc - Segment focus
o 11.14 Merck and Co. Inc.
o Exhibit 160: Merck and Co. Inc. - Overview
o Exhibit 161: Merck and Co. Inc. - Business segments
o Exhibit 162: Merck and Co. Inc. - Key news
o Exhibit 163: Merck and Co. Inc. - Key offerings
o Exhibit 164: Merck and Co. Inc. - Segment focus
o 11.15 Pfizer Inc.
o Exhibit 165: Pfizer Inc. - Overview
o Exhibit 166: Pfizer Inc. - Product / Service
o Exhibit 167: Pfizer Inc. - Key news
o Exhibit 168: Pfizer Inc. - Key offerings
o 11.16 Sanofi SA
o Exhibit 169: Sanofi SA - Overview
o Exhibit 170: Sanofi SA - Business segments
o Exhibit 171: Sanofi SA - Key news
o Exhibit 172: Sanofi SA - Key offerings
o Exhibit 173: Sanofi SA - Segment focus
o 11.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 174: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 175: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 177: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 178: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12 Appendix
o 12.1 Scope of the report
o 12.2 Inclusions and exclusions checklist
o Exhibit 179: Inclusions checklist
o Exhibit 180: Exclusions checklist
o 12.3 Currency conversion rates for US$
o Exhibit 181: Currency conversion rates for US$
o 12.4 Research methodology
o Exhibit 182: Research methodology
o Exhibit 183: Validation techniques employed for market sizing
o Exhibit 184: Information sources
o 12.5 List of abbreviations
o Exhibit 185: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global acute ischemic stroke therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Thrombolytics - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Thrombolytics - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Thrombolytics - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Thrombolytics - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Anticoagulants - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Anticoagulants - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Antiplatelets - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Antiplatelets - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Antiplatelets - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Antiplatelets - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Antihypertensives - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Antihypertensives - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Antihypertensives - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Antihypertensives - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Other therapeutics - Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Type ($ million)
Exhibits55: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits56: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Distribution Channel
Exhibits58: Data Table on Comparison by Distribution Channel
Exhibits59: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by Distribution Channel ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ million)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: Amgen Inc. - Overview
Exhibits121: Amgen Inc. - Product / Service
Exhibits122: Amgen Inc. - Key offerings
Exhibits123: AstraZeneca Plc - Overview
Exhibits124: AstraZeneca Plc - Product / Service
Exhibits125: AstraZeneca Plc - Key news
Exhibits126: AstraZeneca Plc - Key offerings
Exhibits127: Athersys Inc. - Overview
Exhibits128: Athersys Inc. - Product / Service
Exhibits129: Athersys Inc. - Key offerings
Exhibits130: Bayer AG - Overview
Exhibits131: Bayer AG - Business segments
Exhibits132: Bayer AG - Key offerings
Exhibits133: Bayer AG - Segment focus
Exhibits134: Biogen Inc. - Overview
Exhibits135: Biogen Inc. - Product / Service
Exhibits136: Biogen Inc. - Key offerings
Exhibits137: Boehringer Ingelheim International GmbH - Overview
Exhibits138: Boehringer Ingelheim International GmbH - Business segments
Exhibits139: Boehringer Ingelheim International GmbH - Key news
Exhibits140: Boehringer Ingelheim International GmbH - Key offerings
Exhibits141: Boehringer Ingelheim International GmbH - Segment focus
Exhibits142: Bristol Myers Squibb Co. - Overview
Exhibits143: Bristol Myers Squibb Co. - Product / Service
Exhibits144: Bristol Myers Squibb Co. - Key offerings
Exhibits145: Daiichi Sankyo Co. Ltd. - Overview
Exhibits146: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits147: Daiichi Sankyo Co. Ltd. - Key news
Exhibits148: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits149: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits150: F. Hoffmann La Roche Ltd. - Overview
Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
Exhibits152: F. Hoffmann La Roche Ltd. - Key news
Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits155: Johnson and Johnson - Overview
Exhibits156: Johnson and Johnson - Business segments
Exhibits157: Johnson and Johnson - Key news
Exhibits158: Johnson and Johnson - Key offerings
Exhibits159: Johnson and Johnson - Segment focus
Exhibits160: Medtronic Plc - Overview
Exhibits161: Medtronic Plc - Business segments
Exhibits162: Medtronic Plc - Key news
Exhibits163: Medtronic Plc - Key offerings
Exhibits164: Medtronic Plc - Segment focus
Exhibits165: Merck and Co. Inc. - Overview
Exhibits166: Merck and Co. Inc. - Business segments
Exhibits167: Merck and Co. Inc. - Key news
Exhibits168: Merck and Co. Inc. - Key offerings
Exhibits169: Merck and Co. Inc. - Segment focus
Exhibits170: Pfizer Inc. - Overview
Exhibits171: Pfizer Inc. - Product / Service
Exhibits172: Pfizer Inc. - Key news
Exhibits173: Pfizer Inc. - Key offerings
Exhibits174: Sanofi SA - Overview
Exhibits175: Sanofi SA - Business segments
Exhibits176: Sanofi SA - Key news
Exhibits177: Sanofi SA - Key offerings
Exhibits178: Sanofi SA - Segment focus
Exhibits179: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits180: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits181: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits182: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits183: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits184: Inclusions checklist
Exhibits185: Exclusions checklist
Exhibits186: Currency conversion rates for US$
Exhibits187: Research methodology
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Information sources
Exhibits190: List of abbreviations